Ind-Swift Limited
NSE: INDSWFTLTD.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Gopal Munjal
- Employees
- 1,054
- Headquarters
- Chandigarh, India
- IPO year
- 2004
- Market cap
- ₹853.6M
- Website
- https://www.indswiftltd.com
Loading INDSWFTLTD…
Loading profile data…Frequently asked questions about INDSWFTLTD
What does Ind-Swift Limited (INDSWFTLTD.NS) do?
Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom...
Where does INDSWFTLTD.NS trade?
Ind-Swift Limited (INDSWFTLTD.NS) trades on the National Stock Exchange of India.
What sector is INDSWFTLTD.NS in?
Ind-Swift Limited (INDSWFTLTD.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ind-Swift Limited?
Gopal Munjal is the chief executive officer of Ind-Swift Limited (INDSWFTLTD.NS).
Where is Ind-Swift Limited headquartered?
Ind-Swift Limited is headquartered in India.
Does INDSWFTLTD.NS pay a dividend?
Ind-Swift Limited (INDSWFTLTD.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INDSWFTLTD.NS go public?
Ind-Swift Limited (INDSWFTLTD.NS) completed its initial public offering in 2004.